Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview

Emil Scosyrev; James Messing; Katia Noyes; Peter Veazie; Edward Messing

doi:10.1016/j.urolonc.2009.11.005

Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview

Urol Oncol. 2012 Mar-Apr;30(2):126-32. doi: 10.1016/j.urolonc.2009.11.005. Epub 2010 Apr 3.

Authors

Emil Scosyrev¹, James Messing, Katia Noyes, Peter Veazie, Edward Messing

Affiliation

¹ Department of Community and Preventive Medicine, University of Rochester, Rochester, NY 14642, USA.

PMID: 20363162
DOI: 10.1016/j.urolonc.2009.11.005

Abstract

The Surveillance, Epidemiology, and End Results (SEER) program is a commonly used data source in cancer research. This article provides an introduction to the SEER database, describes important data items available from SEER on the most commonly diagnosed urologic malignancies (prostate, bladder, and kidney cancers), and reviews limitations of SEER data for urologic oncology research.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Biomedical Research*
Humans
Research Design*
SEER Program
United States / epidemiology
Urologic Neoplasms / epidemiology*